ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,432, issued on April 29, was assigned to Sun Pharmaceutical Industries Inc. (Princeton, N.J.).
"Treatment of hair loss disorders with deuterated JAK inhibitors" was invented by James V. Cassella (Essex, Conn.) and Christopher L. Brummel (Marlborough, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a JAK-inhibition-responsive condition (such as a hair loss disorder) in a human subject in need thereof, the method comprising administering to the human subject a therapeutically effective amount of Compound (I) or a pharmaceutically acceptable salt thereof, wherein each position designated specifically as deuterium has at least 9...